Correlation Between Scopus Biopharma and Intellipharmaceutics

Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Intellipharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Intellipharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scopus Biopharma and Intellipharmaceutics International, you can compare the effects of market volatilities on Scopus Biopharma and Intellipharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Intellipharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Intellipharmaceutics.

Diversification Opportunities for Scopus Biopharma and Intellipharmaceutics

0.12

Correlation Coefficient

Scopus Biopharma  Intellipharmaceutics

Average diversification

The 3 months correlation between Scopus and Intellipharmaceutics is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Intellipharmaceutics Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellipharmaceutics and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Intellipharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellipharmaceutics has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Intellipharmaceutics go up and down completely randomly.

Pair Corralation between Scopus Biopharma and Intellipharmaceutics

If you would invest  3.80  in Intellipharmaceutics International on October 27, 2024 and sell it today you would earn a total of  0.00  from holding Intellipharmaceutics International or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Scopus Biopharma  vs.  Intellipharmaceutics Internati

Scopus Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scopus Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Scopus Biopharma is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Intellipharmaceutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Scopus Biopharma and Intellipharmaceutics

The main advantage of trading using opposite Scopus Biopharma and Intellipharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Intellipharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellipharmaceutics will offset losses from the drop in Intellipharmaceutics' long position.

The idea behind Scopus Biopharma and Intellipharmaceutics International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.